The potential for citrate to reinforce epigenetic therapy by promoting apoptosis.
Warburg effect
apoptosis
citrate
drug resistance
epigenetic drug
necroptosis
Journal
Trends in endocrinology and metabolism: TEM
ISSN: 1879-3061
Titre abrégé: Trends Endocrinol Metab
Pays: United States
ID NLM: 9001516
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
15
03
2023
revised:
04
07
2023
accepted:
18
07
2023
medline:
15
9
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
ppublish
Résumé
Epigenetic drugs induce ATP depletion, promoting a glycolysis-to-oxidative phosphorylation (OXPHOS) shift which sometimes favors tumor growth by promoting necroptosis over apoptosis. To restore effective apoptosis in tumors, we propose that the administration of citrate could inhibit ATP production, activate caspase-8 (a key necroptosis inhibitor), and downregulate key anti-apoptotic proteins (Bcl-xL and MCL1).
Identifiants
pubmed: 37550099
pii: S1043-2760(23)00133-9
doi: 10.1016/j.tem.2023.07.002
pii:
doi:
Substances chimiques
Citric Acid
2968PHW8QP
bcl-X Protein
0
Citrates
0
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
586-589Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors have no conflicts of interest to declare.